Enodia Therapeutics
Health
· Headquartered in France 🇫🇷
Track Enodia Therapeutics
— get Health deals in free daily digest
Overview
Enodia Therapeutics has raised €20.7 million (approximately $25 million) in seed financing to enhance its discovery platform that utilizes proteomics and machine learning for developing small molecules that degrade disease-driving proteins. The funding round was co-led by Elaia, Pfizer Ventures, and Bpifrance, with additional participation from various investors including Wallonie Entreprendre and the Institut Pasteur.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Elaia, Pfizer Ventures, Bpifrance, Wallonie Entreprendre, Institut Pasteur
Enodia Therapeutics has raised €20.7 million (approximately $25 million) in seed financing to enhance its discovery platform that utilizes proteomics and machine learning for developing small molecules that degrade disease-driving proteins. The funding round was co-led by Elaia, Pfizer Ventures, and Bpifrance, with additional participation from various investors including Wallonie Entreprendre and the Institut Pasteur.